Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines

S. Paukovcekova, D. Valik, J. Sterba, R. Veselska

. 2020 ; 21 (18) : . [pub] 20200909

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21012152

Grant support
LO1413 Ministerstvo Školství, Mládeže a Tělovýchovy
LQ1605 Ministerstvo Školství, Mládeže a Tělovýchovy

The main objective of this study was to analyze changes in the antiproliferative effect of vitamin D3, in the form of calcitriol and calcidiol, via its combined application with all-trans retinoic acid (ATRA) in osteosarcoma cell lines. The response to treatment with calcitriol and calcidiol alone was specific for each cell line. Nevertheless, we observed an enhanced effect of combined treatment with ATRA and calcitriol in the majority of the cell lines. Although the levels of respective nuclear receptors did not correlate with the sensitivity of cells to these drugs, vitamin D receptor (VDR) upregulation induced by ATRA was found in cell lines that were the most sensitive to the combined treatment. In addition, all these cell lines showed high endogenous levels of retinoic acid receptor α (RARα). Our study confirmed that the combination of calcitriol and ATRA can achieve enhanced antiproliferative effects in human osteosarcoma cell lines in vitro. Moreover, we provide the first evidence that ATRA is able to upregulate VDR expression in human osteosarcoma cells. According to our results, the endogenous levels of RARα and VDR could be used as a predictor of possible synergy between ATRA and calcitriol in osteosarcoma cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012152
003      
CZ-PrNML
005      
20210507102711.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21186591 $2 doi
035    __
$a (PubMed)32916897
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Paukovcekova, Silvia $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic $u Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlarska 2, 61137 Brno, Czech Republic
245    10
$a Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines / $c S. Paukovcekova, D. Valik, J. Sterba, R. Veselska
520    9_
$a The main objective of this study was to analyze changes in the antiproliferative effect of vitamin D3, in the form of calcitriol and calcidiol, via its combined application with all-trans retinoic acid (ATRA) in osteosarcoma cell lines. The response to treatment with calcitriol and calcidiol alone was specific for each cell line. Nevertheless, we observed an enhanced effect of combined treatment with ATRA and calcitriol in the majority of the cell lines. Although the levels of respective nuclear receptors did not correlate with the sensitivity of cells to these drugs, vitamin D receptor (VDR) upregulation induced by ATRA was found in cell lines that were the most sensitive to the combined treatment. In addition, all these cell lines showed high endogenous levels of retinoic acid receptor α (RARα). Our study confirmed that the combination of calcitriol and ATRA can achieve enhanced antiproliferative effects in human osteosarcoma cell lines in vitro. Moreover, we provide the first evidence that ATRA is able to upregulate VDR expression in human osteosarcoma cells. According to our results, the endogenous levels of RARα and VDR could be used as a predictor of possible synergy between ATRA and calcitriol in osteosarcoma cells.
650    _2
$a protinádorové látky $x aplikace a dávkování $7 D000970
650    _2
$a protokoly protinádorové kombinované chemoterapie $7 D000971
650    _2
$a kalcifediol $x aplikace a dávkování $7 D002112
650    _2
$a kalcitriol $x aplikace a dávkování $7 D002117
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a lidé $7 D006801
650    _2
$a osteosarkom $x farmakoterapie $x metabolismus $7 D012516
650    _2
$a receptory kalcitriolu $x metabolismus $7 D018167
650    _2
$a alfa receptor kyseliny retinové $x metabolismus $7 D000072482
650    _2
$a tretinoin $x aplikace a dávkování $7 D014212
650    _2
$a vitaminy $x aplikace a dávkování $7 D014815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Valik, Dalibor $u Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic $u Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 61300 Brno, Czech Republic
700    1_
$a Sterba, Jaroslav $u Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 61300 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 65691 Brno, Czech Republic
700    1_
$a Veselska, Renata $u Laboratory of Tumor Biology, Department of Experimental Biology, Faculty of Science, Masaryk University, Kotlarska 2, 61137 Brno, Czech Republic $u Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 61300 Brno, Czech Republic $u International Clinical Research Center, St. Anne's University Hospital Brno, Pekarska 53, 65691 Brno, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 18 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32916897 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507102710 $b ABA008
999    __
$a ok $b bmc $g 1650511 $s 1132531
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 18 $e 20200909 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a LO1413 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a LQ1605 $p Ministerstvo Školství, Mládeže a Tělovýchovy
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Archiving options